UK trial of 172 heart failure inpatients: early discharge with a wearable subcutaneous furosemide pump gave 4.0 more days alive and out of hospital at 30 days. Heart failure readmissions were more frequent (14% vs 6%), though not significantly.
RCTn = 172
Campbell et al. Early Discharge Strategy Including Subcutaneous Furosemide in Hospitalized Heart Failure